269 related articles for article (PubMed ID: 38114120)
1. [Diosgenin alleviates NAFLD induced by a high-fat diet in rats via mTOR/SREBP-1c/HSP60/MCAD/SCAD signaling pathway].
Chen SW; Yin GL; Song CY; Meng DC; Yu WF; Zhang X; Feng YN; Liang PP; Zhang FX
Zhongguo Zhong Yao Za Zhi; 2023 Oct; 48(19):5304-5314. PubMed ID: 38114120
[TBL] [Abstract][Full Text] [Related]
2. [Effect of diosgenin on mTOR/FASN/HIF-1α/VEGFA expression in rats with non-alcoholic fatty liver disease].
Yin GL; Liang HY; Liang PP; Feng YN; Chen SW; Liu XY; Pan WC; Zhang FX
Zhongguo Zhong Yao Za Zhi; 2023 Apr; 48(7):1760-1769. PubMed ID: 37282950
[TBL] [Abstract][Full Text] [Related]
3. Purendan alleviates non-alcoholic fatty liver disease in aged type 2 diabetic rats via regulating mTOR/S6K1/SREBP-1c signaling pathway.
Fan L; Niu H; Zhao L; Yao R; He X; Lu B; Pang Z
Biomed Pharmacother; 2022 Apr; 148():112697. PubMed ID: 35176709
[TBL] [Abstract][Full Text] [Related]
4. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
Zhang J; Du H; Shen M; Zhao Z; Ye X
J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
[TBL] [Abstract][Full Text] [Related]
5. [Effects of soothing liver and invigorating spleen recipes on SREBP-1c, SCD-1 mRNA and proteins expression in hepatocytes of NAFLD rats].
Xu YJ; Yang QH; Han L; Zhang YP; Liu YZ; Jin L; Yan HZ
Zhong Yao Cai; 2014 Jan; 37(1):80-6. PubMed ID: 25090711
[TBL] [Abstract][Full Text] [Related]
6. [Role and mechanism of action of fibroblast growth factor-21 in reducing triglyceride in nonalcoholic fatty liver disease].
Chen L; Jiang M; Xin Y; Wang J; Liu Y; Jiang X; Xuan S
Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):102-7. PubMed ID: 26983476
[TBL] [Abstract][Full Text] [Related]
7. HCBP6 Is Involved in the Development of Hepatic Steatosis Induced by High-Fat Diet and CCL4 in Rats.
Zheng YP; Zhong XY; Huang YS; Zheng CB
Ann Hepatol; 2018; 17(3):511-518. PubMed ID: 29735802
[TBL] [Abstract][Full Text] [Related]
8. Effect of Dangfei Liganning capsule on liver X receptor α/steroid regulatory element binding protein-1/fatty acid synthase signal pathway in rats with metabolic- associated fatty liver disease.
Xiaoling LI; Fengxia S; Zimeng S; Yingxue Z; Jie LI; Qiuxiang Z
J Tradit Chin Med; 2022 Dec; 42(6):940-947. PubMed ID: 36378052
[TBL] [Abstract][Full Text] [Related]
9. Increased dietary fat contributes to dysregulation of the LKB1/AMPK pathway and increased damage in a mouse model of early-stage ethanol-mediated steatosis.
Shearn CT; Smathers RL; Jiang H; Orlicky DJ; Maclean KN; Petersen DR
J Nutr Biochem; 2013 Aug; 24(8):1436-45. PubMed ID: 23465594
[TBL] [Abstract][Full Text] [Related]
10. [Effect of Fuzi Lizhong decoction in reducing liver injury of rats with non-alcoholic fatty liver via activating AMPK and suppressing NF-κBp65 pathway].
Yang JY; Shi ZH; Ma W; Tao DQ; Liu S; Chen L; Zhou XL
Zhongguo Zhong Yao Za Zhi; 2018 Aug; 43(15):3176-3183. PubMed ID: 30200715
[TBL] [Abstract][Full Text] [Related]
11. [Effect of zhenqing recipe on non-alcoholic fatty liver in type 2 diabetes rats and the expression of SIK1].
Zheng H; Hong SC; Yu J; Wen XY
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Jul; 34(7):846-52. PubMed ID: 25137852
[TBL] [Abstract][Full Text] [Related]
12. Diosgenin ameliorates palmitic acid-induced lipid accumulation via AMPK/ACC/CPT-1A and SREBP-1c/FAS signaling pathways in LO2 cells.
Fang K; Wu F; Chen G; Dong H; Li J; Zhao Y; Xu L; Zou X; Lu F
BMC Complement Altern Med; 2019 Sep; 19(1):255. PubMed ID: 31519174
[TBL] [Abstract][Full Text] [Related]
13. Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway.
Hu J; Hong W; Yao KN; Zhu XH; Chen ZY; Ye L
World J Gastroenterol; 2019 Mar; 25(12):1492-1501. PubMed ID: 30948912
[TBL] [Abstract][Full Text] [Related]
14. Effect of Octreotide on Hepatic Steatosis in Diet-Induced Obesity in Rats.
Li M; Ye T; Wang XX; Li X; Qiang O; Yu T; Tang CW; Liu R
PLoS One; 2016; 11(3):e0152085. PubMed ID: 27002331
[TBL] [Abstract][Full Text] [Related]
15. Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease.
Fu D; Cui H; Zhang Y
Cell Physiol Biochem; 2018; 45(6):2187-2198. PubMed ID: 29550812
[TBL] [Abstract][Full Text] [Related]
16. Icariin Alleviates Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome by Improving Liver Fatty Acid Oxidation and Inhibiting Lipid Accumulation.
Hai Y; Zuo L; Wang M; Zhang R; Wang M; Ren L; Yang C; Wang J
Molecules; 2023 Jan; 28(2):. PubMed ID: 36677577
[TBL] [Abstract][Full Text] [Related]
17. [Effect of Nrf2 and related factors on the progression of nonalcoholic steatohepatitis].
Cai YQ; Zhang LZ; Wang DJ; Chen FM; Chen ZY; Zhu KY; Li JS; Yan MX
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2014 Sep; 30(5):465-70. PubMed ID: 25571645
[TBL] [Abstract][Full Text] [Related]
18. [Effect of Electroacupunctrue Stimulation at "Fenglong"(ST 40) on Expression of SREBP-1 c in Non-alcoholic Fatty Liver Disease Rats].
Yu M; Li G; Tang CL; Gao RQ; Feng QT; Cao J
Zhen Ci Yan Jiu; 2017 Aug; 42(4):308-14. PubMed ID: 29072011
[TBL] [Abstract][Full Text] [Related]
19. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway.
Zhu X; Bian H; Wang L; Sun X; Xu X; Yan H; Xia M; Chang X; Lu Y; Li Y; Xia P; Li X; Gao X
Free Radic Biol Med; 2019 Sep; 141():192-204. PubMed ID: 31226399
[TBL] [Abstract][Full Text] [Related]
20. [Sichuan Dark Tea-Based Medicated Dietary Formula Improves Obesity-Induced Renal Lipid Metabolism Disorder in Mice by Remodeling Gut Microbiota and Short-Chain Fatty Acid Metabolism].
Li H; Zhang L; Huang R; Ren Q; Guo F; Shi M; Yang L; Yu Y; Ma L; Fu P
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 54(6):1112-1120. PubMed ID: 38162058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
